HB1063 • 2026

Opioid antagonist; distribution program, reports.

An Act to amend the Code of Virginia by adding a section numbered 32.1-45.5, relating to Department of Health; opioid antagonist distribution program; reports.

Budget

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor: Hodges
Last action: 2026-04-13
Official status: Acts of Assembly Chapter
Effective date: Not listed

Plain English Breakdown

The official source material does not specify the exact format or content of the quarterly reports beyond basic requirements.

Opioid Antagonist Distribution Program Reporting

This act requires Virginia's Department of Health to maintain a list of agencies and organizations that receive opioid antagonists through its distribution program and submit quarterly and annual reports on the program.

What This Bill Does

Requires the Department of Health to keep a list of all agencies and organizations that request and receive opioid antagonists from its distribution program.
Directs the Department to send a report every quarter to certain committees about which agencies or organizations received what type and amount of opioid antagonist, along with dates.
Instructs the Department to develop a methodology for estimating annual costs of the opioid antagonist distribution program using available data and considerations such as community needs and local resources.
Requires an annual report by December 1st that includes cost estimates for the next fiscal year.

Who It Names or Affects

The Virginia Department of Health
Agencies and organizations receiving opioid antagonists through the distribution program

Terms To Know

Opioid antagonist: A medicine that can reverse or block the effects of opioids, often used to treat overdose.
Fiscal year: The period for which financial statements are prepared and budgets are made, usually from July 1st to June 30th.

Limits and Unknowns

Does not specify the exact format or content of the quarterly reports beyond basic requirements.
Does not detail how the Department will develop its methodology for cost estimation.
The bill does not address who will fund the distribution program.

Bill History

2026-04-13 Governor
Approved by Governor-Chapter 729 (effective 7/1/2026)
2026-04-13 Governor
Acts of Assembly Chapter text (CHAP0729)
2026-03-14 House
Enrolled Bill communicated to Governor on March 14, 2026
2026-03-14 Governor
Governor's Action Deadline 11:59 p.m., April 13, 2026
2026-03-13 House
Signed by Speaker
2026-03-13 Senate
Signed by President
2026-03-13 House
Enrolled
2026-03-13 House
Bill text as passed House and Senate (HB1063ER)
2026-03-13 House
Fiscal Impact Statement from Department of Planning and Budget (HB1063)
2026-03-06 House
Senate substitute agreed to by House (95-Y 1-N 0-A)
2026-03-04 Senate
Read third time
2026-03-04 Senate
Engrossed by Senate - committee substitute
2026-03-04 Senate
Passed Senate with substitute Block Vote (40-Y 0-N 0-A)
2026-03-04 Education and Health
Education and Health Substitute agreed to
2026-03-04 Senate
Passed Senate with substitute Block Vote (40-Y 0-N 0-A)
2026-03-03 Finance and Appropriations
Reported from Finance and Appropriations (14-Y 0-N)
2026-03-03 Senate
Rules suspended
2026-03-03 Senate
Passed by for the day
2026-03-03 Senate
Constitutional reading dispensed Block Vote (on 2nd reading) (40-Y 0-N 0-A)
2026-03-03 Senate
Passed by for the day Block Vote (Voice Vote)
2026-02-27 Education and Health
Committee substitute printed 26108700D-S1
2026-02-27 Education and Health
Fiscal Impact Statement from Department of Planning and Budget (HB1063)
2026-02-26 Education and Health
Reported from Education and Health with substitute and rereferred to Finance and Appropriations (15-Y 0-N)
2026-02-26 Senate
Senate committee offered
2026-02-24 Health
Assigned Education sub: Health
2026-02-17 Senate
Constitutional reading dispensed (on 1st reading)
2026-02-17 Education and Health
Referred to Committee on Education and Health
2026-02-16 House
Read third time and passed House Block Vote (96-Y 0-N 0-A)
2026-02-16 House
Reconsideration of passage agreed to by House
2026-02-16 House
Passed House Block Vote (97-Y 0-N 0-A)
2026-02-13 House
Read second time and engrossed
2026-02-12 House
Read first time
2026-02-10 Health and Human Services
Reported from Health and Human Services (22-Y 0-N)
2026-02-05 Behavioral Health
Subcommittee recommends reporting (8-Y 0-N)
2026-01-23 Behavioral Health
Assigned sub: Behavioral Health
2026-01-19 House
Fiscal Impact Statement from Department of Planning and Budget (HB1063)
2026-01-14 House
Prefiled and ordered printed; Offered 01-14-2026 26103580D
2026-01-14 Health and Human Services
Referred to Committee on Health and Human Services

Official Summary Text

Department of Health; opioid antagonist distribution program; reports.
Directs the Department of Health to maintain a list of agencies and organizations that submit requests for and receive opioid antagonists through its distribution program and requires the Department to submit a quarterly report to the Chairs of the House Committee on Appropriations, the House Committee on Health and Human Services, the Senate Committee on Finance and Appropriations, the Senate Committee on Education and Health, and the chair of the Virginia Opioid Abatement Authority on its distribution of opioid antagonists. The bill requires the Department to submit an annual report to the Joint Commission on Health Care and the Chairs of the House Committee on Appropriations and the Senate Committee on Finance and Appropriations by December 1 of each year estimating the costs of the opioid antagonist distribution program for the following fiscal year using a methodology developed by the Department pursuant to parameters set out in the bill. As introduced, the bill was a recommendation of the Joint Commission on Health Care.

Current Bill Text

Read the full stored bill text

An Act to amend the Code of Virginia by adding a section numbered
32.1-45.5
, relating to Department of Health; opioid antagonist distribution program; reports.
Be it enacted by the General Assembly of Virginia:
1. That the Code of Virginia is amended by adding a section numbered
32.1-45.5
as follows:
§
32.1-45.5
. Opioid antagonist distribution program; reports.
A. The Department shall maintain a list of all agencies and organizations that submit requests for and receive opioid antagonists through its distribution program. At least quarterly, the Department shall submit a report to the Chairs of the House Committee on Appropriations, the House Committee on Health and Human Services, the Senate Committee on Finance and Appropriations, and the Senate Committee on Education and Health and the chair of the Virginia Opioid Abatement Authority with the following information: (i) the name of the agency or organization; (ii) the county, city, or town service area; (iii) the quantity, along with the specific formulation and dosage of opioid antagonist, requested by the agency or organization in its most recent order, and the date the request was made; and (iv) the quantity, along with the specific formulation and dosage of opioid antagonist, received by the agency or organization in response to its most recent order, and the date the request was fulfilled.
B. The Department shall develop a methodology to estimate annual opioid antagonist distribution program costs. In developing such methodology, the Department shall use available data and consider account saturation goals, community needs, local resources, and the costs of products. The Department shall submit an annual report estimating the opioid antagonist distribution program costs for the following fiscal year using such methodology to the Joint Commission on Health Care and the Chairs of the House Committee on Appropriations and the Senate Committee on Finance and Appropriations by December 1 of each year.